Severity
Moderate
FDA Devices recall · Reported March 4, 2026
Software anomaly in the patient positioning system may result in positional discrepancy.
Hitachi, Ltd. Radiation Oncology Systems, Kashiwanoha recalled Brand Name: Hitachi Proton Beam Therapy System Ref: PROBEAT-FR - a moderate-severity action.
Brand Name: Hitachi Proton Beam Therapy System Ref: PROBEAT-FR was recalled by Hitachi, Ltd. Radiation Oncology Systems, Kashiwanoha in March 4, 2026. Reason: Software anomaly in the patient positioning system may result in positional discrepancy.. Check the official notice for the remedy. Verify recall #Z-1429-2026 with the FDA Devices before acting.
The recall
Hitachi, Ltd. Radiation Oncology Systems, Kashiwanoha issued this moderate-severity FDA Devices recall-Software anomaly in the patient positioning system may result in positional discrepancy..
Sourced from official FDA Devices enforcement records. Verify recall #Z-1429-2026 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-1429-2026) was formally reported on March 4, 2026, with the manufacturer initiating the action on February 6, 2026. It is classified under Moderate severity (Class II), with a current status of Ongoing. Hitachi, Ltd. Radiation Oncology Systems, Kashiwanoha is listed as the recalling firm, operating out of Kashiwa, N/A. Federal records list the affected scope as 1.
The documented reason for this recall is: Software anomaly in the patient positioning system may result in positional discrepancy. Distribution data in the federal record shows the product reached: US distribution to states of: TX, Washington DC. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
1
Related Recalls
6
3 from same agency
Brand Name: Hitachi Proton Beam Therapy System Ref: PROBEAT-FR
Software anomaly in the patient positioning system may result in positional discrepancy.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | Z-1429-2026 |
| Date reported | March 4, 2026 |
| Date initiated | February 6, 2026 |
| Recalling firm | Hitachi, Ltd. Radiation Oncology Systems, Kashiwanoha |
| Firm location | Kashiwa, N/A |
| Affected scope | 1 |
| Distribution | US distribution to states of: TX, Washington DC |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported March 4, 2026. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.